## CRWD: CrowdStrike Holdings, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.1% below STRENGTH zone (3.0-6.0%); PEG 4.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($480.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Crowdstrike (CRWD) director Gandhi sells $289k in stock**
- Source: Investing.com | 20251210T010914 | Neutral | Relevance: 98%
- CrowdStrike Holdings, Inc. director Sameer K. Gandhi sold $288,999 worth of Class A common stock on December 5, 2025, through pre-arranged trading plans. These sales occurred while CRWD stock trades near its 52-week high, though InvestingPro analysis suggests it may be overvalued. Despite not being profitable over the last year, analysts foresee the company achieving profitability soon, with several firms raising price targets due to strong Q3 fiscal 2026 earnings and accelerating annual recurring revenue.

**2. CROWDSTRIKE ALERT: Bragar Eagel & Squire, P.C. is Investigating CrowdStrike Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm**
- Source: ConchoValleyHomepage.com | 20251209T210847 | Neutral | Relevance: 97%
-  Bragar Eagel & Squire, P.C., a shareholder rights law firm, is investigating potential claims against CrowdStrike Holdings, Inc. on behalf of long-term stockholders. This follows a class action complaint alleging deficient controls in CrowdStrike's Falcon software updates led to major outages, reputational harm, and legal risks. The investigation encourages affected long-term stockholders to contact the firm.

**3. Palo Alto Networks: Chronosphere And CyberArk Provide A Strong Portfolio For The AI Era**
- Source: Seeking Alpha | 20251209T184600 | Neutral | Relevance: 74%
-  Palo Alto Networks (PANW) maintains a BUY rating and a $234 price target, projecting a ~20% upside after strong Q1 results and raised FY26 guidance. Strategic acquisitions of CyberArk for $25 billion and Chronosphere for $3.35 billion position PANW for leadership in AI-driven cybersecurity. Despite integration risks and competition from CRWD's Falcon LogScale, PANW's platformization strategy and AI focus underpin its growth thesis.

**4. Infrastructure, App & Data Protection**
- Source: DXC Technology | 20251210T050945 | Somewhat-Bullish | Relevance: 73%
-  DXC Technology offers comprehensive cybersecurity solutions for infrastructure, applications, and data, helping organizations navigate the complexities of hybrid environments. They design, install, and integrate perimeter, network, and endpoint solutions with advanced threat protection, ensuring compliance and risk reduction. DXC's services encompass endpoint protection, 24x7 network security monitoring, managed cloud access security broker services, cloud security compliance, and robust zero-trust solutions.

**5. F5 Launches ADSP Program to Unify Multicloud Security**
- Source: Mexico Business News | 20251210T170802 | Somewhat-Bullish | Relevance: 70%
-  F5 has expanded its Application Delivery and Security Platform (ADSP) Partner Program with seven new strategic partners to simplify multicloud security and accelerate enterprise digital services. This initiative aims to provide a unified base for application delivery and security, helping organizations navigate the complexities of hybrid and multicloud environments. The program focuses on technical integrations that enhance interoperability, automate critical functions, and strengthen security capabilities from the endpoint to the network edge.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 23, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Freedom Capital | $550 | $430 | +28% |
| 2025-12-04 | Citigroup | $595 | $575 | +3% |
| 2025-12-04 | Goldman Sachs | $564 | $535 | +5% |
| 2025-12-03 | Macquarie | $485 | $485 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Freedom Capital | up | Buy |
| 2025-12-04 | Citigroup | main | Buy |
| 2025-12-04 | Goldman Sachs | main | Buy |
| 2025-12-03 | Macquarie | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 16 ($28.30M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+1.9%)
- Blackrock Inc.: 8.2% (+1.8%)
- JPMORGAN CHASE & CO: 4.8% (+100.6%)
- State Street Corpora: 4.3% (+1.1%)
- Morgan Stanley: 2.6% (-20.0%)

### Key Risks

1. Heavy insider selling: $28M sold (16 transactions in 90 days).
2. Valuation stretched: PEG 4.1x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 23 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.12 signals overvaluation risk, limited margin of safety. Forward P/E 107.1x stretched relative to 30% growth. Revenue growth strong at 22% YoY. Analyst sentiment positive (23 raises, avg +10%). Insider selling cluster ($28.3M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $130.5B |
| Beta | 1.09 |
| 52W Range | $298.00 - $566.90 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.12 |
| Forward P/E | 107.1 |
| Current P/E | 139.3 |
| YoY Growth | 30.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.0% to 0.1% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.11% (CS: 40) | Neutral |
| RSI_14 | 50.6 | Neutral |
| MACD Histogram | 0.26 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.002x | Above |
| vs SMA200 | 1.142x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $517.65
- **Stop Loss:** $480.85 (7.1% risk)
- **Target:** $554.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 37
- **Position Value:** $19,153.05
- **Portfolio %:** 19.15%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-10 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.94 | $0.96 | +2.0% |
| 2025Q3 | $0.83 | $0.93 | +12.0% |
| 2025Q2 | $0.66 | $0.73 | +10.6% |
| 2025Q1 | $0.86 | $1.03 | +19.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*